Skip to main content
Signal8

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC is an Investment Adviser institutional filer with the SEC under CIK 1232621, reporting 41 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in TANG CAPITAL MANAGEMENT LLC's most recent 13F filing, ranked by reported market value.

  1. AURINIA PHARMACEUTICALS INC (AUPH)
  2. SPYRE THERAPEUTICS INC (SYRE)
  3. MIRUM PHARMACEUTICALS INC (MIRM)
  4. KINIKSA PHARMACEUTICALS INTL (KNSA)
  5. CELCUITY INC (CELC)
  6. CORCEPT THERAPEUTICS INC (CORT)
  7. PTC THERAPEUTICS INC (PTCT)
  8. LAKEFRONT BIOTHERAPEUTICS NV (GLPG)
  9. CAPRICOR THERAPEUTICS INC (CAPR)
  10. TARSUS PHARMACEUTICALS INC (TARS)
/